1. Neuronal Signaling Immunology/Inflammation NF-κB Metabolic Enzyme/Protease
  2. Cholinesterase (ChE) Amyloid-β Tau Protein NOD-like Receptor (NLR) Reactive Oxygen Species Mitochondrial Metabolism
  3. AChE/BChE-IN-23

AChE/BChE-IN-23 (Compound 6e) is an AChE/BChE inhibitor (IC50: 0.91 μM, 1.19 μM and 1.01 μM for hAChE, eq BChE and hBChE, respectively). AChE/BChE-IN-23 has antioxidant activity and inhibits 1-42 and Tau protein aggregation. AChE/BChE-IN-23 also inhibits microglial activation by reducing ROS release and mitochondrial injury. AChE/BChE-IN-23 suppresses NLRP3 inflammasome and pro-inflammatory cytokines in human microglial cells. AChE/BChE-IN-23 also reverses the Scopolamine (HY-N0296)-induced memory impairment in mice model.

For research use only. We do not sell to patients.

AChE/BChE-IN-23 Chemical Structure

AChE/BChE-IN-23 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All Cholinesterase (ChE) Isoform Specific Products:

View All NOD-like Receptor (NLR) Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

AChE/BChE-IN-23 (Compound 6e) is an AChE/BChE inhibitor (IC50: 0.91 μM, 1.19 μM and 1.01 μM for hAChE, eq BChE and hBChE, respectively). AChE/BChE-IN-23 has antioxidant activity and inhibits 1-42 and Tau protein aggregation. AChE/BChE-IN-23 also inhibits microglial activation by reducing ROS release and mitochondrial injury. AChE/BChE-IN-23 suppresses NLRP3 inflammasome and pro-inflammatory cytokines in human microglial cells. AChE/BChE-IN-23 also reverses the Scopolamine (HY-N0296)-induced memory impairment in mice model[1].

IC50 & Target[1]

hAChE

0.91 μM (IC50)

eqBCHE

1.19 μM (IC50)

NLRP3

 

hBCHE

1.02 μM (IC50)

In Vitro

AChE/BChE-IN-23 (5-50 μM) causes propidium iodide (has a binding affinity for AChE enzyme) displacement from AChE (5 μM, 2.06%; 10 μM, 11.78%; 20 μM, 14.47%; 50 μM, 27.53%)[1].
AChE/BChE-IN-23 has antioxidant properties (20 μM; radical scavenging of DPPH: 47.30%, IC50:15.17 μM)[1].
AChE/BChE-IN-23 (3.125 μM, 72 h) effectively inhibits 1-42 (12.5 μM) aggregation[1].
AChE/BChE-IN-23 (1.125 μM, 72 h) effectively inhibits Tau (5 μM) aggregation[1].
AChE/BChE-IN-23 (1-20 μM, 24 h) has no cytotoxicity effect on PC-12 cells[1]..
AChE/BChE-IN-23 (12.5 μM, 24 h) inhibits the activation of microglia by reducing the release of ROS and restoring the mitochondrial membrane potential[1].
AChE/BChE-IN-23 (12.5 μM, 24 h) has anti-inflammatory effect by inhibiting NLRP3 inflammasome and NF-κB expression levels in microglial cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: HMC-3 cells
Concentration: 12.5 μM
Incubation Time: 24 h
Result: Suppressed NLRP3, caspase-1, IL-1β and IL-18 expression.

Immunofluorescence[1]

Cell Line: HMC-3 cells
Concentration: 12.5 μM
Incubation Time: 24 h
Result: Reduced mitochondrial ROS and stabilizes the mitochondrial membrane potential.
In Vivo

AChE/BChE-IN-23 (10 mg/kg, i.p., 14 days) reverses the Scopolamine(HY-N0296)-induced amnesia by enhancing spatial and cognitive memory in the AD mice[1].
AChE/BChE-IN-23 (2000 mg/kg, p.o., 14 days) has no toxicological effect on Swiss albino mice including no increase in overweight, abnormal behavior, convulsions, tremors, or diarrhea associated with acute toxicity[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Scopolamine (1 mg/kg) induced Alzheimer’s disease (AD) model; 6-week-old Swiss albino mice[1]
Dosage: 10 mg/kg
Administration: Intraperitoneal injection (i.p.), 14 days
Result: Decreased escape latency, distance traveled in Morris Water Maze (MWM) experiment.
Increased latency period in passive avoidance.
Increased BDNF and Nr4a2 in brain.
Molecular Weight

367.40

Formula

C19H21N5O3

SMILES

N/C(C1=CC=CC(NC(NCCC2=CNC3=C2C=C(OC)C=C3)=O)=C1)=N\O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
AChE/BChE-IN-23
Cat. No.:
HY-159898
Quantity:
MCE Japan Authorized Agent: